Follow US:
UC Riverside-led research has therapeutic implications for COVID-19 treatment
Inflammatory bowel disease, or IBD, describes Crohn’s disease and ulcerative colitis, two chronic diseases that cause inflammation in the intestines. IBD, which affects about 3 million adults in the United States, is an autoimmune disorder — a condition in which the body’s immune system attacks healthy tissues. Its symptoms include...
UC Riverside-led study in mice and human tissue is the first to show how a disease mutation weakens barrier properties of epithelial cells lining the gut
UC Riverside-led study is the first to show how tofacitinib rescues gut barrier function from overactive immune cells
UC Riverside mouse study will identify mechanisms the gene PTPN2 uses to affect gut cells
UC Riverside-led study is the first to show how tofacitinib affects epithelial cells lining the gut
UC Riverside-led study tested the effects of microgravity on intestinal epithelial cells
